ENDRA Life Financials

NDRA Stock  USD 6.05  0.21  3.60%   
Based on the measurements of operating efficiency obtained from ENDRA Life's historical financial statements, ENDRA Life Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December. At present, ENDRA Life's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 1.2 M, whereas Total Assets are forecasted to decline to about 6.6 M. Key indicators impacting ENDRA Life's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio3.733.3582
Significantly Up
Pretty Stable
The essential information of the day-to-day investment outlook for ENDRA Life includes many different criteria found on its balance sheet. An individual investor should monitor ENDRA Life's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in ENDRA Life.

Net Income

(10.56 Million)

  
Understanding current and past ENDRA Life Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ENDRA Life's financial statements are interrelated, with each one affecting the others. For example, an increase in ENDRA Life's assets may result in an increase in income on the income statement.
Please note, the presentation of ENDRA Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ENDRA Life's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ENDRA Life's management manipulating its earnings.

ENDRA Life Stock Summary

ENDRA Life competes with Burning Rock, Neuronetics, DarioHealth Corp, Sera Prognostics, and Star Equity. ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan. Endra Life operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS29273B1044
CUSIP29273B104 29273B302 29273B401 29273B203
LocationMichigan; U.S.A
Business Address3600 Green Court,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websiteendrainc.com
Phone734 335 0468
CurrencyUSD - US Dollar

ENDRA Life Key Financial Ratios

ENDRA Life Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets7.2M8.8M12.9M9.3M6.8M6.6M
Other Current Liab430.1K430.8K488.1K909.1K340.4K357.6K
Net Tangible Assets4.8M7.2M10.8M7.2M8.3M5.1M
Net Debt(5.5M)(6.5M)(8.8M)(4.3M)(2.4M)(2.6M)
Retained Earnings(45.2M)(57.3M)(68.7M)(81.9M)(91.9M)(87.3M)
Accounts Payable1.3M402.9K791.1K614.0K360.4K569.7K
Cash6.2M7.2M9.5M4.9M2.8M4.7M
Capital Surpluse23.2M33.9M49.9M64.5M74.2M77.9M
Inventory113.4K589.6K1.3M2.6M2.6M2.8M
Other Current Assets130.7K396.8K2.7M992.9K198.9K189.0K
Total Liab2.4M1.6M2.1M2.1M1.1M1.4M
Total Current Assets6.5M8.2M12.1M8.5M3.0M5.7M
Common Stock842.03.4K4.3K317.01.0K1.3K
Net Receivables116.7K390.8K(1.3M)(2.6M)(2.4M)(2.2M)
Short Term Debt364.3K153.0K264.7K180.7K202.3K211.5K
Net Invested Capital5.1M7.5M10.8M7.2M5.7M7.5M
Net Working Capital4.5M7.2M10.6M6.8M2.1M2.0M
Capital Stock843.03.4K4.3K318.01.0K1.9K

ENDRA Life Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense2.4M232.4K267.1K21.5K24.8K23.5K
Gross Profit(115.0K)(165.2K)(224.4K)(234.3K)(275.5K)(261.7K)
Operating Income(10.8M)(11.5M)(11.5M)(13.2M)(10.5M)(11.0M)
Ebit(10.8M)(11.5M)(11.2M)(13.2M)(10.1M)(10.6M)
Research Development6.6M5.9M5.5M6.6M5.0M4.2M
Ebitda(10.8M)(11.3M)(11.0M)(12.9M)(9.8M)(10.3M)
Cost Of Revenue115.0K165.2K224.4K234.3K275.5K187.9K
Income Before Tax(13.3M)(11.7M)(11.2M)(13.2M)(10.1M)(10.6M)
Net Income(15.6M)(12.0M)(11.2M)(13.2M)(10.1M)(10.6M)
Income Tax Expense2.2M241.3K(41.5K)21.5K(1.0)(0.95)

ENDRA Life Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory(54.0K)(476.2K)(695.0K)(1.4M)138.0K144.9K
Change In Cash(297.2K)1.1M2.2M(4.6M)(2.1M)(2.0M)
Net Borrowings175K935.3K2.5M337.1K303.4K288.2K
Free Cash Flow(8.6M)(10.8M)(11.2M)(13.0M)(9.6M)(10.1M)
Depreciation115.0K165.2K224.4K234.3K275.5K145.0K
Other Non Cash Items4.0M2.3M(298.7K)1.4K162.9K154.8K
Capital Expenditures43.6K51.3K45K202.6K33.9K32.2K
Net Income(13.3M)(11.7M)(11.2M)(13.2M)(10.1M)(10.6M)
End Period Cash Flow6.2M7.2M9.5M4.9M2.8M4.7M
Change To Netincome1.6M2.1M1.1M1.2M1.4M1.3M
Investments(43.6K)(75.3K)(45K)(202.6K)(65.6K)(68.8K)

ENDRA Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ENDRA Life's current stock value. Our valuation model uses many indicators to compare ENDRA Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ENDRA Life competition to find correlations between indicators driving ENDRA Life's intrinsic value. More Info.
ENDRA Life Sciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, ENDRA Life's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ENDRA Life's earnings, one of the primary drivers of an investment's value.

ENDRA Life Sciences Systematic Risk

ENDRA Life's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ENDRA Life volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on ENDRA Life Sciences correlated with the market. If Beta is less than 0 ENDRA Life generally moves in the opposite direction as compared to the market. If ENDRA Life Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ENDRA Life Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ENDRA Life is generally in the same direction as the market. If Beta > 1 ENDRA Life moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in ENDRA Life Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ENDRA Life's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of ENDRA Life growth as a starting point in their analysis.

Price Earnings To Growth Ratio

46.22

At present, ENDRA Life's Price Earnings To Growth Ratio is projected to increase significantly based on the last few years of reporting.

ENDRA Life November 28, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of ENDRA Life help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ENDRA Life Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of ENDRA Life Sciences based on widely used predictive technical indicators. In general, we focus on analyzing ENDRA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ENDRA Life's daily price indicators and compare them against related drivers.

Complementary Tools for ENDRA Stock analysis

When running ENDRA Life's price analysis, check to measure ENDRA Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ENDRA Life is operating at the current time. Most of ENDRA Life's value examination focuses on studying past and present price action to predict the probability of ENDRA Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ENDRA Life's price. Additionally, you may evaluate how the addition of ENDRA Life to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios